Skip to contentO
Organon & Co.
O
OGNOrganon & Co. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.51B$1.51Bderived−5.3% vs Q4 2024 Net Income-$205.00M-$205.00MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$741,000,000−17.3% Operating Cash Flowderived$141,000,000−63.8% Free Cash Flowderived$96,000,000−71.3% Margins · derivedGross margin49.2%−7.1 pt vs Q4 2024
Net margin-13.6%−20.4 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 24, 2026 · 55 d after period end